...
机译:氟嘧啶疗法的DPYD基因型引导剂量:四种相关DPYD变体的前瞻性安全分析。
Leiden Univ Med Ctr Leiden Netherlands;
Netherlands Canc Inst Amsterdam Netherlands;
Leiden Univ Med Ctr Leiden Netherlands;
Erasmus Univ Med Ctr Rotterdam Netherlands;
Netherlands Canc Inst Amsterdam Netherlands;
Julius Ctr Hlth Sci &
Primary Care Utrecht Netherlands;
Erasmus Univ Med Ctr Rotterdam Netherlands;
Catharina Hosp Eindhoven Netherlands;
Hosp Gelderse Vallei Ede Netherlands;
Netherlands Canc Inst Amsterdam Netherlands;
Deventer Hosp Deventer Netherlands;
Haaglanden Med Ctr The Hague Netherlands;
Leiden Univ Med Ctr Leiden Netherlands;
Maastricht Univ Med Ctr Maastricht Netherlands;
Franciscus Gasthuis &
Vlietland Rotterdam Netherlands;
Amphia Hosp Breda Netherlands;
Bravis Hosp Roosendaal Netherlands;
Univ Med Ctr Utrecht Utrecht Netherlands;
Wilhelmina Hosp Assen Assen Netherlands;
Laurentius Hosp Roermond Netherlands;
Canisius Wilhelmina Hosp Nijmegen Netherlands;
Netherlands Canc Inst Amsterdam Netherlands;
Netherlands Canc Inst Amsterdam Netherlands;
Netherlands Canc Inst Amsterdam Netherlands;
Amsterdam UMC Amsterdam Netherlands;
Erasmus Univ Med Ctr Rotterdam Netherlands;
Erasmus Univ Med Ctr Rotterdam Netherlands;
Leiden Univ Med Ctr Leiden Netherlands;
Netherlands Canc Inst Amsterdam Netherlands;
Leiden Univ Med Ctr Leiden Netherlands;
Univ Utrecht Utrecht Netherlands;
机译:氟嘧啶疗法的DPYD基因型引导剂量:四种相关DPYD变体的前瞻性安全分析。
机译:DPYD基因型引导剂量个体化,提高氟嘧啶治疗的患者安全性:呼叫药物标签更新
机译:携带DPYD DPYD * 2A变体患者的减少剂量氟嘧啶治疗的有效性和安全性:匹配对分析
机译:残余剂量偏差差分直方图分析,使用进化优化的变换参数进行剂量分布翘曲,可在外部束放射治疗中针对患者进行特定的质量保证
机译:差分P53信号响应于5-fu和依托磷脂在癌症治疗中通过DPYD和CHK2调节毒性
机译:再次探讨二氢嘧啶脱氢酶(DPYD)基因的DPYD * 9A(c.85T C)变体在以氟嘧啶为基础的化学疗法治疗的患者中的临床重要性
机译:氟嘧啶化疗:DPYD基因分型和治疗药物监测的药物替补组和个性化治疗的建议